WINDHOEK: The Cancer Association of Namibia (CAN) has released new statistics revealing the impact of sarcoma and bone cancers on the Namibian population.
These types of cancers have affected approximately 361 per 100 000 Namibians over the past decade, translating to an average of 15 new cases annually.
The data indicates that sarcoma and bone cancers predominantly affect older Namibians, particularly those aged 65 and above.
CAN Chief Executive Officer, Rolf Hansen in an interview with Nampa on Monday said this demographic has seen the highest incidence rates, underscoring the need for targeted awareness and healthcare strategies.
Hansen stated that the numbers were presented in honour of July being designated as Sarcoma and Bone Cancer Awareness Month.
The purpose of the awareness month is to raise public awareness of these illnesses, encourage research efforts, and push for better resources and treatments for fellow Namibians who have been diagnosed.
‘Sarcoma is a type of cancer that originates in t
he bones and soft tissues, including fat, muscle, blood vessels, deep skin tissues, nerves, and fibrous tissues. It is relatively rare compared to other types of cancers. Therefore, it is more difficult to detect and start treatment timeously,’ he said.
In addition to sarcoma and bone cancer, Hansen emphasised the incidence of connective and soft tissue malignancies in Namibia. The country records an average of 48 new instances of these malignancies every year. These results indicate a greater concern about cancer incidence in the country, he said.
‘The Cancer Association of Namibia has stressed the significance of early detection and treatment. The organisation is advocating for improved public awareness and education efforts to help Namibians identify the signs and symptoms of these malignancies. Early diagnosis is critical in improving treatment outcomes and survival rates,’ he stated.
He also stated that research into the origins and treatments of sarcoma and bone tumours is ongoing. CAN promotes local
and worldwide research to better understand these malignancies. Namibia aspires to improve patient outcomes by contributing to the worldwide body of knowledge, Hansen said.
‘The increasing prevalence of sarcoma, bone, and soft tissue malignancies in Namibia is a major public health concern. The Cancer Association of Namibia is devoted to addressing this issue through increased awareness, early detection, better healthcare services, and research. The organisation’s efforts are critical in mitigating the impact of these cancers on Namibians,’ he said.
Source: The Namibia Press Agency